ArticlePloS one2014

TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers.

Ivana Jovčevska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.